Nexus AG/€NXU

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Nexus AG

NEXUS AG is a German software company specializing in e-health solutions for the international healthcare market. Its core products include the NEXUS / HIS clinical information system and NEXUS / DIS diagnostic modules, designed to meet the functional requirements of hospitals, psychiatric clinics, rehabilitation centers, and diagnostic facilities. Founded in 1989, the company is headquartered in Donaueschingen, Germany, and operates in seven European countries with additional support in 23 other countries through certified dealers. With approximately 1,930 employees as of December 31, 2023, NEXUS AG focuses on developing user-friendly software that enhances efficiency and safety in patient care. ([nexus-ehealth.com](https://www.nexus-ehealth.com/company/brief-company-portrait?utm_source=openai))

Ticker

€NXU

Primary listing

XETRA

Industry

Health Care Technology

Employees

1,930

ISIN

DE0005220909

Nexus AG Metrics

BasicAdvanced
€1.2B
37.71
€1.88
0.70
€0.23
0.32%

Bulls say / Bears say

Nexus AG's second quarter 2024 earnings showed an EPS increase to €0.34 from €0.30 in Q2 2023, indicating strong financial performance. (Simply Wall St)
The company announced a dividend increase to €0.22 per share in April 2024, reflecting confidence in its financial health. (Simply Wall St)
Nexus AG's stock was considered 27% undervalued as of July 1, 2024, suggesting potential for price appreciation. (Simply Wall St)
Goldman Sachs Group, Inc. reduced its voting rights in Nexus AG to 4.06% as of December 23, 2024, potentially indicating decreased confidence. (Nasdaq)
UBS Group AG decreased its voting rights in Nexus AG from 5.42% to 4.98% as of December 27, 2024, which may reflect reduced institutional support. (Nasdaq)
The Ministry of Finance on behalf of the State of Norway adjusted its voting rights in Nexus AG to 3.15% as of December 27, 2024, indicating a slight reduction in stake. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 30 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €NXU

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs